June 17, 2026

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated...

recent articles

Definiens continues to demonstrate why their image analysis technology continues to meet increasing challenges and levels of sophistication.  Increasingly the road to the accurate diagnosis and appropriate treatments and...

How to build teamwork, boost productivity, and enhance harmony in your lab’s multi-generational workforce YOUR PRESENTER: Jeff Smith, Principal, Titan Group Justin M. Clark (Moderator), Director of...

What happens when an internist calls a pathologist about a case he does not...

Last month I was fortunate to see a demo of Leica's SCN400 scanner and their image management system provided by SlidePath's Digital Imaging...

Jason Hipp1, Jerome Cheng1, Jeffrey C. Hanson2, Wusheng Yan2, Phil Taylor3, Nan Hu2, JaimeRodriguez-Canales2, Jennifer Hipp2, Michael A. Tangrea2, Michael R. Emmert-Buck2, Ulysses Balis1 1Department of Pathology, University of Michigan School...

New Northern Ireland Biobank will be central to cancer research locally, nationally and internationally i-Path Diagnostics is being has been chosen as the cloud based digital pathology platform to study human tissue samples, improve...

OR

platinum partners

gold partners

Silver Partners

Media Partners